The cell-free DNA (cfDNA) blood collection tube market is ripe with opportunities driven by the rise in lifestyle-related ...
Researchers combined protein biomarkers, cfDNA analysis, and machine learning to open opportunities for early-stage ovarian cancer screening and diagnostics. The cfDNA fragmentome is a genome-wide ...
Fetuses at high risk for cystic fibrosis may be detected by screening of pregnant mothers using reflex to cell-free DNA analysis.
Cancer is a life threatening condition, and its early diagnosis and prevention are the only two things that matter before it ...
MedPage Today on MSN
Add-On Multicancer Early Detection Test Promising Across Various Cancer Types
BERLIN -- Adding a test that predicts cancer signal origin to single standard of care (SoC) screening substantially increased ...
(UroToday.com) The 2025 ESMO annual meeting featured a metastatic castration-resistant prostate cancer (mCRPC) session and a ...
Complementary value of a digital pathology biomarker to post-surgery circulating tumor DNA in risk stratification of stage III colon cancer patients receiving adjuvant chemotherapy. This is an ASCO ...
CNW/ - Medcan, a global leader in proactive health and wellness, announced the Canadian launch of the Galleri® multi-cancer early detection (MCED) test ...
“Our findings show that RNA-based testing can uncover hidden risks in multiple myeloma that DNA tests alone miss,” study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback